Gene expression analysis identifies novel targets for cervical cancer therapy

32Citations
Citations of this article
55Readers
Mendeley users who have this article in their library.

Abstract

Although there has been significant progress in prevention and treatment of cervical cancer, this malignancy is still a leading cause of cancer death for women. Anti-angiogenesis and immunotherapy approaches have been providing survival benefits, however, response rates and durability of response need to be improved. There is a clear need for combination therapies that increase effectiveness of these agents and further improve patient outcome. Previous studies have largely focused on gene expression and molecular pathways in untreated cervix cancer. The goal of this study was to evaluate cancer-specific molecular pathways and their correlation with tumor immune profile in recurrent cervical cancer. Tumor and adjacent normal tissues were used to identify potential combination therapy targets. We found that DNA damage repair pathway genes were significantly overexpressed in the tumor. Based on our results and other recent investigations, we suggest that combination immune checkpoint and PARP inhibitor therapy is a high priority consideration for patients with recurrent, previously treated cervical cancer. We also show that multiple epithelial-mesenchymal transition-related genes, including MAP2K4, ID2, JAK1, FGF2, PIK3R1, AKT3, FGF13, and STAT3 may be potential targets. Interestingly, high-throughput analysis of Cancer Genome Atlas data identified distinct targets, including Fatty acid synthase FASN and Matrix Metallopeptidase 1 MMP1 as novel, promising combination therapy partners.

References Powered by Scopus

Cancer statistics, 2018

7844Citations
N/AReaders
Get full text

Improved survival with bevacizumab in advanced cervical cancer

1176Citations
N/AReaders
Get full text

Human papillomavirus and cervical cancer

890Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Identification of a prognostic immune signature for cervical cancer to predict survival and response to immune checkpoint inhibitors

111Citations
N/AReaders
Get full text

The pyroptotic role of Caspase-3/GSDME signalling pathway among various cancer: A Review

97Citations
N/AReaders
Get full text

FASN promotes lymph node metastasis in cervical cancer via cholesterol reprogramming and lymphangiogenesis

53Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Roszik, J., Ring, K. L., Wani, K. M., Lazar, A. J., Yemelyanova, A. V., Soliman, P. T., … Jazaeri, A. A. (2018). Gene expression analysis identifies novel targets for cervical cancer therapy. Frontiers in Immunology, 9(SEP). https://doi.org/10.3389/fimmu.2018.02102

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 16

62%

Researcher 6

23%

Professor / Associate Prof. 2

8%

Lecturer / Post doc 2

8%

Readers' Discipline

Tooltip

Medicine and Dentistry 11

39%

Biochemistry, Genetics and Molecular Bi... 11

39%

Immunology and Microbiology 4

14%

Chemistry 2

7%

Save time finding and organizing research with Mendeley

Sign up for free